An insight into a novel MYD88 transgenic model being used to investigate WM

Описание к видео An insight into a novel MYD88 transgenic model being used to investigate WM

Ruben Carrasco, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares some insights into a novel MYD88 transgenic model being used to investigate mutations in Waldenström’s macroglobulinemia (WM). This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Комментарии

Информация по комментариям в разработке

Похожие видео